Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis

International Journal of Cancer

Volumn 133, Issue 2, 2013, Pages 446-454

  Van Roekel, Eline H ^a,b   Cheng, Kar K ^a   James, Nicholas D ^a   Wallace, D Michael A ^c   Billingham, Lucinda J ^a   Murray, Paul G ^a   Bryan, Richard T ^a   Zeegers, Maurice P ^a,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

bladder cancer; epidemiology; smoking

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SMOKING; TUMOR VOLUME;

AGE OF ONSET; AGED; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHENOTYPE; PROGNOSIS; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84877795418     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28017     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66: 4-34.
3. Ploeg M, Aben KK, Kiemeney LA,. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-93.
4. Morrison AS, Proppe KH, Verhoek WG, et al. Histologic features of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. Int J Cancer 1982; 30: 701-05.
5. Kaufman DS, Shipley WU, Feldman AS,. Bladder cancer. Lancet 2009; 374: 239-49.
6. Kiemeney LA, Witjes JA, Verbeek AL, et al. The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group. Br J Cancer 1993; 67: 806-12.
7. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73-8.
8. Zeegers MP, Kellen E, Buntinx F, et al. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004; 21: 392-401.
9. Zeegers MP, Tan FE, Dorant E, et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89: 630-39.
10. Thompson IM, Peek M, Rodriguez FR,. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. J Urol 1987; 137: 401-03.
11. Garcia Mediero JM, Angulo CJ, Lujan GM, et al. [Smoking habit and superficial bladder tumours' natural history]. Actas Urol Esp 2007; 31: 349-54.
12. Mohseni MG, Zand S, Aghamir SM,. Effect of smoking on prognostic factors of transitional cell carcinoma of the bladder. Urol J 2004; 1: 250-52.
13. Wallerand H, Bakkar AA, de Medina SG, et al. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis 2005; 26: 177-84.
14. Ouerhani S, Rouissi K, Marrakchi R, et al. Do smoking and polymorphisms in xenobiotic metabolizing enzymes affect the histological stage and grade of bladder tumors? Bull Cancer 2009; 96: E23-E29.
15. Sturgeon SR, Hartge P, Silverman DT, et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994; 5: 218-25.
16. Jiang X, Castelao JE, Yuan JM, et al. Cigarette smoking and subtypes of bladder cancer. Int J Cancer 2012; 130: 896-901.
17. Hinotsu S, Akaza H, Miki T, et al. Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association. Int J Urol 2009; 16: 64-9.
18. Khedhiri S, Stambouli N, Ouerhani S, et al. The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis. J Cancer Res Clin Oncol 2010; 136: 1111-16.
19. Prout GR Jr, Wesley MN, Greenberg RS, et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer 2000; 89: 1349-58.
20. Brooks DR, Geller AC, Chang J, et al. Occupation, smoking, and the risk of high-grade invasive bladder cancer in Missouri. Am J Ind Med 1992; 21: 699-713.
21. Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999; 86: 2337-45.
22. Michalek AM, Cummings KM, Pontes JE,. Cigarette smoking, tumor recurrence, and survival from bladder cancer. Prev Med 1985; 14: 92-8.
23. Lockwood K,. On the etiology of bladder tumors in Kobenhavn- Frederiksberg. An inquiry of 369 patients and 369 controls. Acta Pathol Microbiol Scand Suppl 1961; 51 (Suppl 145): 1-166.
24. Chen CH, Shun CT, Huang KH, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 2007; 100: 281-86.
25. Persad R, Fleming C, Chern HD, et al. Environmental procarcinogen hypothesis of bladder cancer in humans: dapsone hydroxylation as a susceptibility risk factor for aggressive bladder cancer. Urol Oncol 1997; 3: 18-26.
26. Jensen OM, Wahrendorf J, Blettner M, et al. The Copenhagen case-control study of bladder cancer: role of smoking in invasive and non-invasive bladder tumours. J Epidemiol Community Health 1987; 41: 30-6.
27. Lopez-Beltran A, Croghan GA, Croghan I, et al. Prognostic factors in survival of bladder cancer. Cancer 1992; 70: 799-807.
28. Nieder AM, MacKinnon JA, Fleming LE, et al. Bladder cancer clusters in Florida: identifying populations at risk. J Urol 2009; 182: 46-50.
29. Hayes RB, Friedell GH, Zahm SH, et al. Are the known bladder cancer risk-factors associated with more advanced bladder cancer? Cancer Causes Control 1993; 4: 157-62.
30. Serretta V, Altieri V, Morgia G, et al. Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma. Urol Int 2009; 82: 318-23.
31. Carpenter AA,. Clinical experience with transitional cell carcinoma of the bladder with special reference to smoking. J Urol 1989; 141: 527-28.
32. Raitanen MP, Nieminen P, Tammela TL,. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. Br J Urol 1995; 76: 470-4.
33. Zeegers MP, Bryan RT, Langford C, et al. The West Midlands Bladder Cancer Prognosis Programme: rationale and design. BJU Int 2010; 105: 784-8.
34. Sobin LH, Wittekind C, eds. Union Internationale Contre le Cancer. TNM classification of malignant tumors, vol. 6. New York: Wiley-Liss, 2002.
35. Mostofi FK, Sobin LH, Torloni H,. Histological typing of urinary bladder tumours. Geneva: World Health Organization, 1973.
36. Chade DC, Shariat SF, Godoy G, et al. Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. J Urol 2010; 184: 74-80.
37. StataCorp LP. Stata/IC 11.0 statistical package for Windows, 2009.
38. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010; 42: 978-84.
39. Moore LE, Baris DR, Figueroa JD, et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 2011; 32: 182-9.
40. Wu XR,. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005; 5: 713-25.
41. Goebell PJ, Knowles MA,. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol 2010; 28: 409-28.
42. Esrig D, Elmajian D, Groshen S, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994; 331: 1259-64.
43. Masters JR, Vani UD, Grigor KM, et al. Can p53 staining be used to identify patients with aggressive superficial bladder cancer? J Pathol 2003; 200: 74-81.
44. Huang RY, Chen GG,. Cigarette smoking, cyclooxygenase-2 pathway and cancer. Biochim Biophys Acta 2011; 1815: 158-69.
45. Egan KM, Lawson JA, Fries S, et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 2004; 306: 1954-7.
46. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994; 84: 1086-93.
47. Wallace DM, Bryan RT, Dunn JA, et al. Delay and survival in bladder cancer. BJU Int 2002; 89: 868-78.
48. Aveyard P, Adab P, Cheng KK, et al. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 2002; 90: 228-39.
49. Strope SA, Montie JE,. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 2008; 180: 31-7; discussion 37.